Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| Tofacitinib blocks IFN-regulated biomarker genes in skin fibroblasts and keratinocytes in a systemic sclerosis trial. | JCI Insight | 2022 | 35943798 | PubTator, text mining | PubMed |
| In Virus Veritas Lockdown and Happiness Under COVID-19. | Soc Indic Res | 2022 | 35937979 | PubTator, text mining | PubMed |
| Strategies of Epstein-Barr virus to evade innate antiviral immunity of its human host. | Front Microbiol | 2022 | 35935191 | PubTator, text mining | PubMed |
| shRNA‑mediated knockdown of KNTC1 inhibits non-small-cell lung cancer through regulating PSMB8. | Cell Death Dis | 2022 | 35933405 | PubTator, text mining | PubMed |
| Immune Characteristics and Prognosis Analysis of the Proteasome 20S Subunit Beta 9 in Lower-Grade Gliomas. | Front Oncol | 2022 | 35928883 | PubTator, text mining | PubMed |
| NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer. | Front Immunol | 2022 | 35911687 | PubTator, text mining | PubMed |
| The Association of Epstein-Barr Virus With Cancer. | Cureus | 2022 | 35911302 | PubTator, text mining | PubMed |
| A clinically relevant pulse treatment generates a bortezomib-resistant myeloma cell line that lacks proteasome mutations and is sensitive to Bcl-2 inhibitor venetoclax. | Sci Rep | 2022 | 35896610 | PubTator, text mining | PubMed |
| CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases. | Pathogens | 2022 | 35894054 | PubTator, text mining | PubMed |
| Precision Anti-Cancer Medicines by Oligonucleotide Therapeutics in Clinical Research Targeting Undruggable Proteins and Non-Coding RNAs. | Pharmaceutics | 2022 | 35890348 | PubTator, text mining | PubMed |
| Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing. | Biomedicines | 2022 | 35884979 | PubTator, text mining | PubMed |
| The Epigenetic Regulatory Protein CBX2 Promotes mTORC1 Signalling and Inhibits DREAM Complex Activity to Drive Breast Cancer Cell Growth. | Cancers (Basel) | 2022 | 35884550 | PubTator, text mining | PubMed |
| The Clinical Chameleon of Autoinflammatory Diseases in Children. | Cells | 2022 | 35883675 | PubTator, text mining | PubMed |
| Ubiquitin-proteasome system in diabetic retinopathy. | PeerJ | 2022 | 35873915 | PubTator, text mining | PubMed |
| Targeting Proteasomes in Cancer and Infectious Disease: A Parallel Strategy to Treat Malignancies and Microbes. | Front Cell Infect Microbiol | 2022 | 35873166 | PubTator, text mining | PubMed |
| The emergence of tumor-infiltrating lymphocytes in nasopharyngeal carcinoma: Predictive value and immunotherapy implications. | Genes Dis | 2022 | 35873027 | PubTator, text mining | PubMed |
| Protein scaffolds: antibody alternatives for cancer diagnosis and therapy. | RSC Chem Biol | 2022 | 35866165 | PubTator, text mining | PubMed |
| PSMC1 variant causes a novel neurological syndrome. | Clin Genet | 2022 | 35861243 | PubTator, text mining | PubMed |
| Uncovering Signals of Positive Selection in Peruvian Populations from Three Ecological Regions. | Mol Biol Evol | 2022 | 35860855 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=35